Cyclo G6

 Call Us: 1300 657720

G6 banner

 

 e btn brochure

Efficacy - Confidence in IOP Control

Long-term results from National University Hospital (NUHS), Singapore prospective clinical study1 showed:

  • 33% IOP reduction at 18 months, N = 38 patients
  • 61% med reduction (2.1 to 1.3)
  • 73% success rate with 1.3 sessions

 

NUHS-Chart multi-center-chart

 

Excellent Safety Profile

The MicroPulse® P3 Glaucoma Device powered by the CYCLO G6™ Glaucoma Laser System enables a versatile procedure with multiple safety benefits:

  • Non-Incisional
  • Minimal to no inflammation post-op
  • Patient downtime is significantly low
  • Repeatable
  • Predictable

pre-treatment   post-treatment

2014 Randomized study shows MicroPulse P3 has similar IOP reduction as G-Probe with higher success rate and no hypotony

 

  MicroPulse TSCPCTSCPC
Pre-op IOP 36.5 mmHg 35.0 mmHg
N Total of 48 24 pts 24 pts
Average Follow-up 17.5 months 17.5 months
IOP Reduction 45% 45%
Success Rate (<21 mmHg at 18 months) 75% 29%
Prologed Hypotony 0 5
Mean # of Treatments 1.6 1.3

Customer support and forms

Company Contacts

Product Navigation

Home

Common Products

Detection, Lasers & Surgical

Dry Eye Products

Dispensing and Lab

Links

mivision NZoptics eyetalk
 logo-RANZCO  Optometry-Aust-FINAL sm  Orthoptics
   logo-odma   ODMA17
     
   

S5 Box